News Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-05-22 pm EDT			5-day change	1st Jan Change
153.5 ^USD	+1.49%		+0.54%	-2.07%

May. 22	Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	RE
May. 22	Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	May. 22	RE
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	May. 22	MT
Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American	May. 22	MT
Proposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc Litigation	May. 22	BU
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	May. 22	MT
Engitix Announces Appointment of Matthew Edwards Ph.D., as SVP Discovery and Emma Huang Ph.D., as VP Data Sciences	May. 22	AQ
Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship	May. 21	MT
TREMFYA (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major secondary endpoints, including highly statistically significant rates of endoscopic remission	May. 21	AQ
Novel biologic could offer ulcerative colitis symptomatic remission	May. 21	AQ
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	May. 21	AQ
J&J: positive trial for Tremfya in ulcerative colitis	May. 21	CF
Valneva Names New Chief Scientific Officer	May. 21	MT
Global markets live: Apple, Tesla, Pfizer, AstraZeneca, Microsoft...	May. 20
Ex-dividend day	May. 19	FA
J&J-backed startup Rapport files for US IPO	May. 17	RE
Johnson & Johnson : to Participate in the 2024 RBC Capital Markets Global Healthcare Conference Transcript	May. 17	PU
J&J-Linked Rapport Therapeutics Files For IPO	May. 17	DJ
J&J: towards acquisition of Proteologix for $850 million	May. 17	CF
Johnson & Johnson to Buy Proteologix For $850 Million in Cash	May. 16	MT
Sector Update: Health Care Stocks Steady Premarket Thursday	May. 16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST